Researchers are working to identify genetic variations that may help signal which acute myeloid leukemia patients will benefit or not benefit from one of the newest antileukemic agents.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/X...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/X...